Can histologic features predict neoadjuvant therapy response in rectal adenocarcinoma?
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 226, 153608
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Watch and Wait?—Elevated Pretreatment CEA Is Associated with Decreased Pathological Complete Response in Rectal CancerJournal of Gastrointestinal Surgery, 2016
- Rectal cancer: An evidence-based update for primary care providersWorld Journal of Gastroenterology, 2015
- Clinical tumour size and nodal status predict pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancerInternational Journal of Colorectal Disease, 2014
- Clinical Prediction of Pathological Complete Response After Preoperative Chemoradiotherapy for Rectal CancerDiseases of the Colon & Rectum, 2013
- Prognostic value of microsatellite instability in sporadic locally advanced rectal cancer following neoadjuvant radiotherapyHistopathology, 2012
- International study group on rectal cancer regression grading: interobserver variability with commonly used regression grading systemsHuman Pathology, 2012
- Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal CancerJournal of Clinical Oncology, 2012
- Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer Decreases Distant Recurrence and Could Eradicate Local RecurrenceAnnals of Surgical Oncology, 2011
- Signet ring cell histology and non-circumferential tumors predict pathological complete response following neoadjuvant chemoradiation in rectal cancersInternational Journal of Colorectal Disease, 2010
- Transanal Excision of Locally Advanced Rectal Cancers Downstaged Using Neoadjuvant Chemoradiotherapy1Journal of the American College of Surgeons, 2002